1.
|
Phase: Phase IV
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: QLT-PHO-ECI-01, NCI-V98-1399
|
|
2.
|
Phase: Phase III
Type: Prevention, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: QLT-PHO-BAR-01, NCI-V98-1398
|
|
3.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: HEALTHONE-43892, HEALTHONE-1A, HEALTHONE-CA43892, RPCI-DS-9802, NCI-V99-1525, NCT00003788
|
|
4.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UUMC-2086, NCI-V88-0322
|
|
5.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: ACC-D73-P20, NCI-V89-0079
|
|
6.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: ACC-D73-P17, NCI-V89-0076
|
|
7.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: ACC-D73-P18, NCI-V89-0077
|
|
8.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: ACC-D73-P19, NCI-V89-0078
|
|
9.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: ACC-D73-P15, NCI-V90-0031
|
|
10.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: TCSC-D73-P32, NCI-V91-0140
|
|
11.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-93-C-0204C, NCI-T93-0108N, T93-0108
|
|
12.
|
Phase: Phase II, Phase I
Type: Prevention, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: TCSC-9307, NCI-V94-0483
|
|
13.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: RPMI-PPC-797, NCI-V87-0200
|
|
14.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: RPMI-PPC-878, NCI-V87-0199
|
|
15.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: RPMI-DS-8914, NCI-V90-0116
|
|
16.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: LUMC-IND-33410, NCI-V92-0018
|
|
17.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RPCI-DS-93-23, NCI-G97-1138, NCT00002935
|
|
18.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RPCI-DS-95-12, NCI-G97-1168
|
|
19.
|
Phase: Phase II
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: RPCI-DS-94-10, NCI-V97-1196, NCT00002964
|
|
20.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RPCI-DS-96-45, NCI-G97-1246
|
|
21.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-99015, NCI-G99-1525, NCT00003923
|
|
22.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: RPMI-PPC-803, NCI-V87-0204
|
|
23.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: RPMI-PPC-881, NCI-V87-0201
|
|
24.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: RPMI-PPC-813, NCI-V87-0206
|
|
25.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor:
Protocol IDs: RPMI-PPC-892, NCI-V87-0205
|
